CuraTeQ Biologics completes Phase 3 clinical study for Denosumab biosimilar
Conducted entirely in Europe across forty sites in five countries, this rigorous study met all clinical endpoints
Conducted entirely in Europe across forty sites in five countries, this rigorous study met all clinical endpoints
The inspection concluded with zero form 483 observations
ProBioGen will oversee the design, construction, and operation of the 4,600-square-meter GMP manufacturing unit
Encouraging early detection and breaking the silence around men’s health
The conference stressed a multi-dimensional approach required to address Antimicrobial Resistance (AMR), focusing on the right approach and strengthening awareness
The survey revealed that the proportion of individuals experiencing constant thoughts about food throughout the day declined by 46 percent after starting Wegovy
The study further confirmed that GAL-101 effectively crosses the blood-brain barrier
The HCl gas is generated continuously which is absorbed in the water scrubber using a chilled falling film system
The cGMP-4 facility will further strengthen the company's ability to serve global partners
The Ma’anshan site approval covers pastilles, oral liquids, and powders
Subscribe To Our Newsletter & Stay Updated